| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC47594 | Bictegravir Sodium | Bictegravir (GS-9883) Sodium is a novel and potent inhibitor of HIV-1 integrase, specifically targets IN strand transfer activity with an IC50 of 7.5 nM. |
|
| DC47595 | Zanamivir-Cholesterol Conjugate | Zanamivir–cholesterol conjugate is a long-acting neuraminidase inhibitor with potent efficacy against drug-resistant influenza viruses. |
|
| DC47601 | PMEDAP | PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP has anti-murine cytomegalovirus (MCMV) activity. PMEDAP is a very potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality. |
|
| DC47602 | Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium | Tenofovir-C3-O-C12-trimethylsilylacetylene (ammonium) exhibits substantially longer t1/2 values than tenofovir in human liver microsomes, potent anti-HIV activity in vitro, and enhances pharmacokinetic properties in vivo. |
|
| DC47603 | Tenofovir-C3-O-C15-CF3 ammonium | Tenofovir-C3-O-C15-CF3 (ammonium) exhibits substantially longer t1/2 values than tenofovir in human liver microsomes, potent anti-HIV activity in vitro, and enhances pharmacokinetic properties in vivo. |
|
| DC47604 | GPS491 Featured | GPS491 (EC50 = 0.47 μM) suppresses expression of the HIV-1 structural protein Gag and alters HIV-1 RNA accumulation, decreasing the abundance of RNAs encoding the structural proteins while increasing levels of viral RNAs encoding the regulatory proteins. |
|
| DC47605 | HIV-1 inhibitor-9 | HIV-1 inhibitor-9 is found to be potent inhibitor against the wild-type (WT) HIV-1 strain or multiple NNRTI-resistant strains at low nanomolar levels. |
|
| DC47606 | Melliferone | Melliferone is a triterpenoid found in Brazilian propolis. |
|
| DC47607 | Antiviral agent 9 | Antiviral agent 9 reaches a single-digit picomolar EC50 value (0.006 nM) against HIV-1 and nearly 300-fold higher selectivity index (SI) compared to tenofovir alafenamide fumarate (TAF). |
|
| DC47640 | Fungicide5 | Fungicide5 is a fungicide candidate targeting succinate dehydrogenase (Ki = 0.095 μM). |
|
| DC47641 | Benzyl 2-hydroxy-6-methoxybenzoate | Benzyl 2-hydroxy-6-methoxybenzoate shows the strongest antifungal effect, with IC50 of 25–26 μg/mL for both fungal strains. |
|
| DC47642 | Antifungal agent 20 | Antifungal agent 20 exhibits remarkable antifungal activity against Colletotrichum gloeosprioides, Rhizoctonia solani, Phytophthora nicotianae var. nicotianae, Diplodia pinea, Colletotrichum acutatum, and Fusarium oxysporum f. sp. niveum. |
|
| DC47643 | Phenazine-1-carboxylic acid | Phenazine-1-carboxylic acid exhibits strong antifungal activity against phytopathogenic fungi. |
|
| DC47644 | 5-epi-Jinkoheremol | 5-epi-Jinkoheremol exhibits more potent fungicidal activity than validamycin. |
|
| DC47645 | Antifungal agent 18 | Antifungal agent 18 is a novel antifungal agent for the treatment of fungal infection. |
|
| DC47646 | Antifungal agent 15 | Antifungal agent 15 has the most potent activity with EC50 values of 0.52 and 0.50 μg/mL against S. sclerotiorum and B. cinerea, respectively. |
|
| DC47647 | Antifungal agent 14 | Antifungal agent 14 exhibits broad-spectrum activity against the fungal strains with excellent minimum inhibitory concentration values. |
|
| DC47648 | Nystatin A3 | Nystatin A3, produced by Streptomyces noursei, a biologically active component of nystatin complex. Antibiotic activity |
|
| DC47649 | Fungicide4 | Fungicide4 shows the high activity against the P. infestans strain. |
|
| DC47650 | Debneyol | Debneyol exhibits more potent fungicidal activity than validamycin. |
|
| DC47651 | Antifungal agent 13 | Antifungal agent 13 exhibits remarkable antifungal activity against Sclerotinia sclerotiorum with an EC50 value of 1.25 mg/L. |
|
| DC47652 | Antifungal agent 19 | Antifungal agent 19 shows the potent antifungal activity (EC50 = 0.72 μM). |
|
| DC47653 | Antifungal agent 17 | Antifungal agent 17 exhibits excellent antifungal properties against B. cinerea with an EC50 value of 2.86 μg/mL. |
|
| DC47654 | Antifungal agent 16 | Antifungal agent 16 displays considerable antibacterial activity and superior antifungal activity with reference to ciprofloxacin and fluconazole, respectively. |
|
| DC47655 | Antifungal agent 12 | Antifungal agent 12 is a novel fluconazole-based compound with promising antifungal activities. |
|
| DC47656 | Antifungal agent 11 | Antifungal agent 11 shows the promising antifungal activity. |
|
| DC47663 | WIN 54954 | WIN 54954 is a broad-spectrum antipicornavirus agent. WIN 54954 is effectiveness against human rhinovirus, echovirus 9 and enterovirus infections. |
|
| DC47723 | Decamethoxine | Decamethoxine (Septefril) is a cationic gemini surfactant. Decamethoxine exhibits strong bactericidal and fungicidal effects. Decamethoxine modifies the permeability of the microbial cell membrane, resulting in the destruction and death of diverse microorganisms. |
|
| DC47724 | Hikizimycin | Hikizimycin is a potent anthelmintic and antibacterial natural product. |
|
| DC47725 | ARX-1796 | ARX-1796 (AV-006), an Avibactam prodrug, is an orally bioavailable β-lactamase inhibitor. Avibactam has a spectrum of inhibition of class A and C β-lactamases, including ESBLs, AmpC and Klebsiella pneumoniae carbapenemase (KPC) enzymes. |
|
